PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-9.56
Negative P/E while Healthcare median is -0.77. Seth Klarman would scrutinize path to profitability versus peers.
7.48
P/S 1.1-1.25x Healthcare median of 6.30. John Neff would demand superior growth or margins to justify premium.
0.43
P/B less than half the Healthcare median of 1.81. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-35.61
Negative FCF while Healthcare median P/FCF is -3.70. Seth Klarman would investigate cash flow improvement potential.
-42.40
Negative operating cash flow while Healthcare median P/OCF is -2.75. Seth Klarman would investigate operational improvement potential.
0.43
Fair value ratio less than half the Healthcare median of 1.81. Joel Greenblatt would investigate if this discount is justified.
-2.62%
Negative earnings while Healthcare median yield is -2.58%. Seth Klarman would investigate path to profitability.
-2.81%
Negative FCF while Healthcare median yield is -2.48%. Seth Klarman would investigate cash flow improvement potential.